While the US Food and Drug Administration has been working to speed up the time it takes for drugs to garner approval, Commissioner Margaret Hamburg says that the sequester may slow those efforts, the Boston Herald reports. Speaking to the Massachusetts Biotechnology Council annual meeting attendees, Hamburg added that she would like Congress to allow FDA to access the user fees it collects to pay for its operating costs.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.